Steven Rosen, MD

Robert H. Lurie Comprehensive Cancer ...Chicago, Illinois - 60611 Northwestern University, Northwestern Medical Faculty ...Chicago, Illinois - 60611 Northwestern UniversityChicago, Illinois - 60611 |
- CLINICAL TRIALS 4
- CONDITIONS20
- INTERVENTIONS7
- SINCE2005

Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma
October 2006 - October 2016

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
January 2007 - July 2013

Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer
February 2010 - February 2014

A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma
September 2005 - December 2012
Breast Neoplasms
Nervous System Neoplasms
Central Nervous System Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Neoplasms
Neoplasm Metastasis
Myelodysplastic Syndromes
Preleukemia
Lymphoma, T-Cell
Precancerous Conditions
Myeloproliferative Disorders
Lymphoma, Large-Cell, Immunoblastic
Myelofibrosis
Myeloid Metaplasia
Lymphoproliferative Disorders
Burkitt Lymphoma
Gemcitabine Hydrochloride
Bortezomib
Nab-Paclitaxel
Cyclosporins
Pemetrexed
Regimen B
Regimen A



